Insulin-like growth factor-II/mannose 6-phosphate receptor overexpression reduces growth of choriocarcinoma cells in vitro and in vivo

Endocrinology

Volumn 143, Issue 11, 2002, Pages 4287-4294

  O'Gorman, David B ^a   Weiss, Jocelyn ^a   Hettiaratchi, Anusha ^a   Firth, Sue M ^a   Scott, Carolyn D ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR;

ARTICLE; CANCER GROWTH; CHORIOCARCINOMA; CONTROLLED STUDY; DNA SYNTHESIS; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GROWTH INHIBITION; GROWTH RATE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN SECRETION; RECEPTOR UPREGULATION;

EID: 0036827629     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-220548     Document Type: Article

References (46)

1. MacDonald RG, Tepper MA, Clairmont KB, Perregaux SB, Czech MP 1989 Serum form of the rat insulin-like growth factor II/mannose 6-phosphate receptor is truncated in the carboxyl-terminal domain. J Biol Chem 264:3256-3261
2. Nissley P, Kiess W, Sklar MM 1991 The insulin-like growth factor-II/mannose 6-phosphate receptor. In: Le Roith D, ed. Insulin-like Growth Factors: Molecular and Cellular Aspects. Boca Raton, FL: CRC Press; 111-150
3. Devi GR, De Souza AT, Byrd JC, Jirtle RL, MacDonald RG 1999 Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers. Cancer Res 59:4314-4319
4. Byrd JC, Devi GR, De Souza AT, Jirtle RL, MacDonald RG 1999 Disruption of ligand binding to the insulin-like growth factor II/mannose 6-phosphate receptor by cancer-associated missense mutations. J Biol Chem 274:24408-24416
5. De Souza AT, Hankins GR, Washington MK, Fine RL, Orton TC, Jirtle RL 1995 Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors. Oncogene 10:1725-1729
6. Hankins GR, De Souza AT, Bentley RC, Patel MR, Marks JR, Iglehart JD, Jirtle RL 1996 M6P/IGF2 receptor: A candidate breast tumor suppressor gene. Oncogene 12:2003-2009
7. Braulke T, Tippmer S, Neher E, Von Figura K 1989 Regulation of the mannose 6-phosphate/IGF II receptor expression at the cell surface by mannose 6-phosphate, insulin like growth factors and epidermal growth factor. EMBO J 8:681-686
8. Ouyang H, Shiwaku HO, Hagiwara H, Miura K, Abe T, Kato Y, Ohtani H, Shiiba K, Souza RF, Meltzer SJ, Horii A 1997 The insulin-like growth factor II receptor gene is mutated in genetically unstable cancers of the endometrium, stomach, and colorectum. Cancer Res 57:1851-1854
9. O'Gorman DB, Costello M, Weiss J, Firth SM, Scott CD 1999 Decreased insulin-like growth factor-II/mannose 6-phosphate receptor expression enhances tumorigenicity in JEG-3 cells. Cancer Res 59:5692-5694
10. Polychronakos C, Guyda HJ, Janthly U, Posner BI 1990 Effects of mannose-6-phosphate on receptor-mediated endocytosis of insulin-like growth factor-II. Endocrinology 127:1861-1866
11. Wang S, Souza RF, Kong D, Yin J, Smolinski KN, Zou TT, Frank T, Young J, Flanders KC, Sugimura H, Abraham JM, Meltzer SJ 1997 Deficient transforming growth factor-beta1 activation and excessive insulin-like growth factor II (IGFII) expression in IGFII receptor-mutant tumors. Cancer Res 57:2543-2546
12. Osipo C, Dorman S, Frankfater A 2001 Loss of insulin-like growth factor II receptor expression promotes growth in cancer by increasing intracellular signaling from both IGF-I and insulin receptors. Exp Cell Res 264:388-396
13. Nykjaer A, Christensen EI, Vorum H, Hager H, Petersen CM, Roigaard H, Min HY, Vilhardt F, Moller LB, Kornfeld S, Gliemann J 1998 Mannose 6-phosphate/insulin-like growth factor-II receptor targets the urokinase receptor to lysosomes via a novel binding interaction. J Cell Biol 141:815-828
14. Lustig-Yariv O, Schulze E, Komitowski D, Erdmann V, Schneider T, de Groot N, Hochberg A 1997 The expression of the imprinted genes H19 and IGF-2 in choriocarcinoma cell lines. Is H19 a tumor suppressor gene? Oncogene 15:169-177
15. Fagin JA, Pixley S, Slanina S, Ong J, Melmed S 1987 Insulin-like growth factor I gene expression in GH3 rat pituitary cells: Messenger ribonucleic acid content, immunocytochemistry, and secretion. Endocrinology 120:2037-2043
16. Ritvos O, Ranta T, Jalkanen J, Suikkari AM, Voutilainen R, Bohn H, Rutanen EM 1988 Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells. Endocrinology 122:2150-2157
17. Ohlsson R 1989 Growth factors, protooncogenes and human placental development. Cell Differ Dev 28:1-15
18. Oshima A, Nolan CM, Kyle JW, Grubb JH, Sly WSC 1988 The human cation-independent mannose 6-phosphate receptor. Cloning and sequence of the full-length cDNA and expression of functional receptor in COS cells. J Biol Chem 263:2553-2562
19. Costello M, Baxter RC, Scott CD 1999 Regulation of soluble insulin-like growth factor II/mannose 6-phosphate receptor in human serum: Measurement by enzyme-linked immunosorbent assay. J Clin Endocrinol Metab 84:611-617
20. Sambrook J, Fritsch EF, Maniatis T 1989 Molecular Cloning: A Laboratory Manual. 2nd Ed. New York: Cold Spring Harbor Press; 7.43-7.46
21. Laborda J 1991 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res 19:3998
22. Cesarone CF, Bolognesi C, Santi L 1979 Improved microfluorometric DNA determination in biological material using 33258 Hoechst. Anal Biochem 100:188-197
23. Baxter RC 1990 Radioimmunoassay for insulin-like growth factor (IGF) II: Interference by pure IGF-binding proteins. J Immunoassay 11:445-458
24. Clairmont KB, Czech MP 1991 Extracellular release as the major degradative pathway of the insulin-like growth factor II/mannose 6-phosphate receptor. J Biol Chem 266:12131-12134
25. Scott CD, Ballesteros M, Madrid J, Baxter RC 1996 Soluble insulin-like growth factor-II/mannose 6-P receptor inhibits deoxyribonucleic acid synthesis in cultured rat hepatocytes. Endocrinology 137:873-878
26. Scott C, Weiss J 2000 Soluble insulin-like growth factor II/mannose 6-phosphate receptor inhibits DNA synthesis in insulin-like growth factor II sensitive cells. J Cell Physiol 182:62-68
27. Ritvos O, Eramaa M 1991 Adenosine 3′, 5′-monophosphate and phorbol ester induce transforming growth factor-beta 1 messenger ribonucleic acid levels in choriocarcinoma cells. Endocrinology 129:2240-2245
28. Graham CH, Connelly I, MacDougall JR, Kerbel RS, Stetler-Stevenson WG, Lala PK 1994 Resistance of malignant trophoblast cells to both the antiproliferative and anti-invasive effects of transforming growth factor-β. Exp Cell Res 214:93-99
29. Martin JL, Baxter RC 1991 Transforming growth factor-beta stimulates production of insulin-like growth factor-binding protein-3 by human skin fibroblasts. Endocrinology 128:1425-1433
30. Baxter RC, Martin JL, Wood MH 1987 Two immunoreactive binding proteins for insulin-like growth factors in human amniotic fluid: Relationship to fetal maturity. J Clin Endocrinol Metab 65:423-431
31. Ho PJ, Baxter RC 1997 Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia. Clin Endocrinol (Oxf) 46:333-342
32. Baxter RC, Martin JL 1986 Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma. J Clin Invest 78:1504-1512
33. Baxter RC, Saunders H 1992 Radioimmunoassay of insulin-like growth factor-binding protein-6 in human serum and other body fluids. J Endocrinol 134:133-139
34. Mohan S, Baylink DJ 1995 Development of a simple valid method for the complete removal of insulin-like growth factor (IGF)-binding proteins from IGFs in human serum and other biological fluids: Comparison with acid-ethanol treatment and C-18 Sep-Pak separation. J Clin Endocrinol Metab 80: 637-647
35. Lobel P, Fujimoto K, Ye RD, Griffiths G, Kornfeld S 1989 Mutations in the cytoplasmic domain of the 275 kDa mannose 6-phosphate receptor differentially alter lysosomal enzyme sorting and endocytosis. Cell 57:787-796
36. Rochefort H, Capony F, Garcia M 1990 Cathepsin D: A protease involved in breast cancer metastasis. Cancer Metastasis Rev 9:321-331
37. De Souza AT, Hankins GR, Washington MK, Orton TC, Jirtle RL 1995 M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet 11:447-449
38. Creek KE, Sly WS 1984 The role of the phosphomannosyl receptor in the transport of acid hydrolases to lysosomes. In: Dingle JT, Dean RT, Sly WS, eds. Lysosomes in Biology and Pathology. Amsterdam: Elsevier; vol 7:63-82
39. Von Figura K, Hasilik A 1986 Lysosomal enzymes and their receptors. Annu Rev Biochem 55:167-193
40. Ludwig T, Munier-Lehmann H, Bauer U, Hollinshead M, Ovitt C, Lobel P, Hoflack B 1994 Differential sorting of lysosomal enzymes in mannose 6-phosphate receptor-deficient fibroblasts. EMBO J 13:3430-3437
41. Dennis PA, Rifkin DB 1991 Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci USA 88:580-584
42. Jirtle RL, Carr BI, Scott CD 1991 Modulation of insulin-like growth factor-II/mannose 6-phosphate receptors and transforming growth factor-β during liver regeneration. J Biol Chem 266:22444-224450
43. Barrack ER 1997 TGF beta in prostate cancer: A growth inhibitor that can enhance tumorigenicity. Prostate 31:61-70
44. Reiss M 1997 Transforming growth factor-β and cancer: A love-hate relationship? Oncol Res 9:447-457
45. Mohanam S, Gladson CL, Rao CN, Rao JS 1999 Biological significance of the expression of urokinase-type plasminogen activator receptors (uPARs) in brain tumors. Front Biosci 4:D178-D187
46. Mustjoki S, Alitalo R, Stephens RW, Vaheri A 1999 Plasminogen activation in human leukemia and in normal hematopoietic cells. APMIS 107:144-149